GMED Globus Medical Inc - Class A

  1. Stocks
  2. Healthcare
  3. NYSE: GMED

Price (delayed)

$72.26

Market cap

$9.57B

P/E Ratio

17.45

Dividend/share

N/A

EPS

$4.14

Enterprise value

$9.24B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 87

Based in Audubon, Pennsylvania, Globus Medical, Inc. was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing ...

Highlights
The P/E is 67% less than the 5-year quarterly average of 55.9 and 8% less than the last 4 quarters average of 19.9
The EPS has grown by 32% year-on-year and by 4.3% since the previous quarter
GMED's quick ratio is down by 13% since the previous quarter but it is up by 8% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.globusmedical.com
Peers: SYK OFIX ATEC

Key stats

What are the main financial stats of GMED

GMED stock price

How has the Globus Medical stock price performed over time
Intraday
-4.15%
1 week
-11.27%
1 month
-5.22%
1 year
-14.7%
YTD
-17.24%
QTD
-3.52%

Financial performance

How have Globus Medical's revenue and profit performed over time
Revenue
$3.14B
Gross profit
$2.17B
Operating income
$679.71M
Net income
$557.64M
Gross margin
69.1%
Net margin
17.8%
The operating income has soared by 83% YoY and by 6% QoQ
The company's operating margin has surged by 61% YoY and by 6% QoQ
The company's net income rose by 32% YoY and by 4.1% QoQ
The gross profit has grown by 20% YoY

Price vs fundamentals

How does GMED's price correlate with its fundamentals

Growth

What is Globus Medical's growth rate over time

Valuation

What is Globus Medical stock price valuation
GMED P/E details
P/E
17.45
P/B
2.02
P/S
3.09
EV/EBIT
13.68
EV/EBITDA
9.69
EV/Sales
2.94
The P/E is 67% less than the 5-year quarterly average of 55.9 and 8% less than the last 4 quarters average of 19.9
The EPS has grown by 32% year-on-year and by 4.3% since the previous quarter
The stock's P/B is 19% less than its 5-year quarterly average of 2.6 and 8% less than its last 4 quarters average of 2.3
GMED's equity is up by 9% year-on-year
GMED's P/S is 31% lower than its 5-year quarterly average of 4.7 and 11% lower than its last 4 quarters average of 3.6
Globus Medical's revenue has increased by 13% YoY

Efficiency

How efficient is Globus Medical business performance
The return on sales has grown by 30% year-on-year and by 5% since the previous quarter
GMED's ROIC is up by 24% year-on-year
The ROA is up by 21% year-on-year and by 3% since the previous quarter
Globus Medical's return on equity has increased by 18% YoY

Dividends

What is GMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GMED.

Financial health

How did Globus Medical financials performed over time
GMED's quick ratio is down by 13% since the previous quarter but it is up by 8% year-on-year
GMED's total assets is up by 8% year-on-year
The debt is 98% smaller than the equity
The company's debt to equity fell by 33% YoY
The debt has declined by 10% year-on-year and by 3.3% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.